BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Riganti C, Contino M. New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer. Int J Mol Sci 2019;20:E4783. [PMID: 31561494 DOI: 10.3390/ijms20194783] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Ashrafi A, Akter Z, Modareszadeh P, Modareszadeh P, Berisha E, Alemi PS, Chacon Castro MDC, Deese AR, Zhang L. Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance. Cancers 2022;14:4562. [DOI: 10.3390/cancers14194562] [Reference Citation Analysis]
2 Khan MM, Torchilin VP. Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors. Cancers 2022;14:4123. [DOI: 10.3390/cancers14174123] [Reference Citation Analysis]
3 Lee J, Davaa E, Jiang Y, Shin K, Kim MH, An H, Kim J, Cho SK, Yang S. Pheophorbide A and SN38 conjugated hyaluronan nanoparticles for photodynamic- and cascadic chemotherapy of cancer stem-like ovarian cancer. Carbohydrate Polymers 2022;289:119455. [DOI: 10.1016/j.carbpol.2022.119455] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sobierajska P, Serwotka-Suszczak A, Targonska S, Szymanski D, Marycz K, Wiglusz RJ. Synergistic Effect of Toceranib and Nanohydroxyapatite as a Drug Delivery Platform-Physicochemical Properties and In Vitro Studies on Mastocytoma Cells. Int J Mol Sci 2022;23:1944. [PMID: 35216060 DOI: 10.3390/ijms23041944] [Reference Citation Analysis]
5 Liskova A, Samec M, Koklesova L, Brockmueller A, Zhai K, Abdellatif B, Siddiqui M, Biringer K, Kudela E, Pec M, Gadanec LK, Šudomová M, Hassan STS, Zulli A, Shakibaei M, Giordano FA, Büsselberg D, Golubnitschaja O, Kubatka P. Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles. EPMA J 2021;:1-22. [PMID: 34025826 DOI: 10.1007/s13167-021-00242-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shawky AM, Abdalla AN, Ibrahim NA, Abourehab MAS, Gouda AM. Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities. Eur J Med Chem 2021;218:113403. [PMID: 33823396 DOI: 10.1016/j.ejmech.2021.113403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Guimarães RS, Rodrigues CF, Fernandes N, de Melo-Diogo D, Ferreira P, Correia IJ, Moreira AF. Combinatorial delivery of doxorubicin and acridine orange by gold core silica shell nanospheres functionalized with poly(ethylene glycol) and 4-methoxybenzamide for cancer targeted therapy. J Inorg Biochem 2021;219:111433. [PMID: 33887612 DOI: 10.1016/j.jinorgbio.2021.111433] [Reference Citation Analysis]
8 Ashrafizadeh M, Ang HL, Moghadam ER, Mohammadi S, Zarrin V, Hushmandi K, Samarghandian S, Zarrabi A, Najafi M, Mohammadinejad R, Kumar AP. MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy. Biomolecules 2020;10:E1040. [PMID: 32664703 DOI: 10.3390/biom10071040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
9 Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, Abotaleb M, Biringer K, Kudela E, Danko J, Shakibaei M, Kwon TK, Büsselberg D, Kubatka P. Flavonoids in Cancer Metastasis. Cancers (Basel) 2020;12:E1498. [PMID: 32521759 DOI: 10.3390/cancers12061498] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 16.5] [Reference Citation Analysis]